The global nicotinamide adenine dinucleotide market was valued at $400.1 Million in 2021 and it is expected to reach $1812 Million at a CAGR of 14.4% between 2022 and 2032. The market for nicotinamide adenine dinucleotide is expected to expand significantly through 2032 as a result of changing beauty standards around the globe. Additionally, the booming pharmaceutical sector and the rising prevalence of chronic diseases are projected to boost market growth throughout the forecast period.
By region, North America has led this market with significant growth over the past few years.
The market for nicotinamide adenine dinucleotide is expected to expand significantly through 2032 as a result of changing beauty standards around the globe. Additionally, the booming pharmaceutical sector and the rising prevalence of chronic diseases are projected to boost market growth throughout the forecast period. The pharmaceutical and cosmetics businesses saw increased product uptake, nevertheless, because of improvements in NAD supplements and goods as well as a rise in customer knowledge of the advantages of the items.
Source: SAI Research
The pyridine nucleotide nicotinamide adenine dinucleotide is crucial for a variety of important cellular processes, including DNA repair, epigenetically controlled gene expression, oxidative phosphorylation, ATP synthesis, intracellular calcium signaling, and immunological functions. In addition, according to recent research, raising NAD levels can significantly lessen oxidative cell damage in catabolic tissue, such as the brain. To effectively realize the numerous advantages of healthy sirtuin activity, stimulation of intracellular NAD anabolism provides a prospective treatment option for age-associated degenerative illnesses in general.
Moreover, to stay ahead of the competition and drive overall business growth, prominent market players in the nicotinamide adenine dinucleotide market spend a lot of time increasing their product portfolio and conducting intensive R&D initiatives. Due to its numerous health advantages, such as enhancing athletic performance, lowering chronic fatigue syndrome, controlling high cholesterol, treating depression, lowering blood pressure, assisting in anti-aging, maintaining the effects of alcohol on the liver, and more, nicotinamide adenine dinucleotide, or NAD, is receiving positive attention. Over the years 2022–2032, increasing pharmaceutical utilization and demand is anticipated to propel nicotinamide adenine dinucleotide market expansion.
Based on grade type, the food grade category accounted for most of the market share and is expected to dominate the market during the forecast period. Due to the multiple benefits of NAD supplementation, including higher immunity & energy, improved memory, and lower blood pressure & cholesterol, the food-grade NAD segment is expected to amass significant gains over the projected period. The significant role of NAD as a substrate and cofactor for numerous essential biological processes, such as DNA repair and epigenetically controlled gene expression, is anticipated to further propel the market. However, the pharmaceutical-grade segment is also expected to become the second-growing category with more growth opportunities. In addition, Pharmaceutical grade supplements are those that are created to ensure an incredibly high quality of purity and maximal absorption.
In terms of application type, the dietary supplement segment holds most of the share and is also anticipated to dominate the market over the forecast period. An alternate form of the B3 vitamin is nicotinamide adenine dinucleotide (NAD+), which can be obtained through dietary sources and supplements as well as body synthesis. It is essential for more than 500 enzymatic reactions and plays a crucial part in controlling practically all significant biological functions. Demand for nutritional supplements has increased as a result of the growing popularity of functional products and supplementation.
Geographically, the North American region has dominated the market and is also expected to hold its dominant position in the competitive market. It is believed that a significant factor driving area industry statistics is the existence of numerous NAD-based product manufacturing facilities and feed manufacturing businesses. In addition, rising consumer knowledge of the benefits to their health is a major element supporting the expansion of the regional market. Additionally, the region's increasing prevalence of cardiovascular disorders will increase demand for nicotinamide adenine dinucleotide and propel the market for it to expand.
According to the study, key players such as Catalent Inc (U.S), Juvilant Pharmova (India), Himedia Laboratories Pvt Ltd (India), Krackeler Scientific (U.S), Lasons India Pvt Ltd (India), Novo Nordisk (Denmark), NutriScience Innovations (U.S), OYC Americas (U.S), Otto Chemie Pvt Ltd (India), TCI Chemicals (Japan), among others are leading the global nicotinamide adenine dinucleotide market.
|Market Size in 2021||US$ 400.1 Million|
|Market Volume Projection by 2032||US$ 1812 Million|
|Forecast Period 2022 to 2032 CAGR||14.4%|
|Historical Data||2019, 2020 and 2021|
|Forecast Period||2022 to 2032|
By Grade Type: Pharmaceutical Grade, Food Grade &Others
By Application Type: Dietary Supplement, Pharmaceutical Industry & Others
North America, Europe, Asia-Pacific, LAMEA
|Companies covered||Catalent Inc (U.S), Juvilant Pharmova (India), Himedia Laboratories Pvt Ltd (India), Krackeler Scientific (U.S), Lasons India Pvt Ltd (India), Novo Nordisk (Denmark), NutriScience Innovations (U.S), OYC Americas (U.S), Otto Chemie Pvt Ltd (India), TCI Chemicals (Japan), among others.|
The Global Nicotinamide Adenine Dinucleotide Market Has Been Segmented Into:
The Global Nicotinamide Adenine Dinucleotide Market – by Grade Type:
The Global Nicotinamide Adenine Dinucleotide Market – by Application Type:
The Global Nicotinamide Adenine Dinucleotide Market – by Regions: